Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Recurrence × Radiation × Clear all

Sponsor

Conditions

Glioblastoma 19 Breast Neoplasms 19 Carcinoma, Non-Small-Cell Lung 12 Rectal Neoplasms 11 Prostatic Neoplasms 11 Gliosarcoma 11 Esophageal Neoplasms 9 Brain Neoplasms 9 Adenocarcinoma Of Esophagus 8 Uterine Cervical Neoplasms 7 Lung Neoplasms 7 Head and Neck Neoplasms 7 Pancreatic Neoplasms 6 Neoplasms 6 Central Nervous System Neoplasms 6 Carcinoma, Squamous Cell 6 Squamous Cell Carcinoma of Head and Neck 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Neoplasm Metastasis 5 Glioma 5 Astrocytoma 5 Urinary Bladder Neoplasms 4 Sarcoma 4 Melanoma 4 Leukemia, Myeloid, Acute 4 Endometrial Neoplasms 4 Burkitt Lymphoma 4 Breast Neoplasms, Male 4 Rhabdomyosarcoma 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3

Interventions

Cyclophosphamide 31 Dexamethasone 28 Cytarabine 20 fludarabine phosphate 18 Rituximab 18 Lenalidomide 16 Methotrexate 15 Bortezomib 15 fludarabine 14 Calcium Dobesilate 14 Whole-Body Irradiation 13 pembrolizumab 12 Peripheral Blood Stem Cell Transplantation 12 Mycophenolic Acid 12 Etoposide 12 Melphalan 11 Gemcitabine 11 Filgrastim 11 Cyclosporine 11 Paclitaxel 10 pomalidomide 9 Carboplatin 9 Vincristine 8 Panobinostat 8 Clofarabine 8 Cetuximab 8 Busulfan 8 Brentuximab Vedotin 8 Bevacizumab 8 carfilzomib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡